Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2006 | 1 |
2007 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells.
Am J Physiol Renal Physiol. 2008 Jun;294(6):F1287-95. doi: 10.1152/ajprenal.00017.2008. Epub 2008 Mar 26.
Am J Physiol Renal Physiol. 2008.
PMID: 18367662
Free article.
PAI-1 as a target in kidney disease.
Huang Y, Noble NA.
Huang Y, et al.
Curr Drug Targets. 2007 Sep;8(9):1007-15. doi: 10.2174/138945007781662373.
Curr Drug Targets. 2007.
PMID: 17896952
Review.
Item in Clipboard
Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis.
Huang Y, Border WA, Lawrence DA, Noble NA.
Huang Y, et al.
Kidney Int. 2006 Aug;70(3):515-22. doi: 10.1038/sj.ki.5000353. Epub 2006 Jun 21.
Kidney Int. 2006.
PMID: 16788698
Free article.
Item in Clipboard
Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect.
Yu L, Border WA, Anderson I, McCourt M, Huang Y, Noble NA.
Yu L, et al.
Kidney Int. 2004 Nov;66(5):1774-84. doi: 10.1111/j.1523-1755.2004.00901.x.
Kidney Int. 2004.
PMID: 15496148
Free article.
Item in Clipboard
Cite
Cite